Aug 21, 2026 05:15PM
Aug 6, 2026 12:31PM
Aug 6, 2026 07:01AM
Jul 30, 2026 08:00AM
Jul 17, 2026 05:15PM
Jun 19, 2026 05:15PM
Jun 3, 2026 04:09PM Iovance receives Australia approval for melanoma therapy Amtagvi
Jun 3, 2026 04:05PM
Jun 1, 2026 08:30AM
Jun 1, 2026 07:31AM
Jun 1, 2026 07:30AM
May 22, 2026 05:15PM
May 21, 2026 08:05AM
May 7, 2026 07:05AM Iovance Biotherapeutics Highlights Positive First Quarter 2026 Results, Business Achievements and Corporate Updates
Apr 27, 2026 08:01AM
Apr 17, 2026 05:15PM
Apr 10, 2026 01:20PM
Mar 20, 2026 05:15PM
Feb 26, 2026 08:00AM
Feb 24, 2026 07:00AM
Feb 24, 2026 07:00AM Iovance Biotherapeutics Highlights Strong Fourth Quarter and Full Year 2025 Results, Business Achievements and Corporate Updates
Feb 20, 2026 05:15PM
Feb 11, 2026 04:05PM
Feb 5, 2026 05:15PM
Feb 5, 2026 05:15PM
Jan 16, 2026 05:15PM
Dec 19, 2025 05:15PM
Nov 21, 2025 05:15PM Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Nov 6, 2025 08:00AM
Nov 3, 2025 07:01AM
Nov 3, 2025 07:00AM
Oct 23, 2025 04:05PM
Oct 17, 2025 05:15PM
Sep 19, 2025 05:00PM
Aug 29, 2025 08:30AM Iovance Biotherapeutics to Present at Upcoming Conferences
Aug 22, 2025 05:15PM
Aug 18, 2025 04:15PM
Aug 18, 2025 04:15PM
Aug 7, 2025 04:01PM
Jul 24, 2025 04:05PM
Jul 22, 2025 08:50AM
Jul 18, 2025 05:15PM Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Jul 15, 2025 07:31AM
Jul 15, 2025 07:30AM
Jul 14, 2025 07:30AM
Jul 14, 2025 07:30AM
Jul 10, 2025 04:01PM
Jun 30, 2025 12:02PM
Jun 27, 2025 12:00PM Scott+Scott Attorneys at Law LLP Continues to Remind Investors of The Ongoing Securities Action Against Iovance Biotherapeutics, Inc. (IOVA)
Jun 25, 2025 12:02PM

329,914 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All